AML Variable Terminology

Preferred Label : AML Variable Terminology;

NCIt synonyms : Acute Myeloid Leukemia Variable Terminology;

NCIt definition : Terms that have been designated as being a variable within the PCDC Terminology and AML project.;

NCI Metathesaurus CUI : CL1407919;

Details

Origin ID

C174018;

UMLS CUI

C5420527;

Semantic type(s)
- Intellectual Product [UMLS semantic type]
concept_is_in_subset
- PCDC Terminology [NCIt concept]
subset_includes_concept
- ANC Threshold at Response [NCIt concept]
- ANC at Response [NCIt concept]
- Adverse Event [NCIt concept]
- Adverse Event Attribution to Product or Procedure [NCIt concept]
- Adverse Event Code [NCIt concept]
- Adverse Event Grading System [NCIt concept]
- Adverse Event Intervention [NCIt concept]
- Adverse Event Medication [NCIt concept]
- Adverse Event Outcome [NCIt concept]
- Adverse Event Pathogen [NCIt concept]
- Adverse Event Severity Grade [NCIt concept]
- Adverse Event System Grading Version [NCIt concept]
- Age in Days When Lost to Follow-up [NCIt concept]
- Age in Days When Off Protocol Therapy or Study [NCIt concept]
- Age in Days at Course ANC 500 [NCIt concept]
- Age in Days at Disease Phase [NCIt concept]
- Age in Days at End of Concomitant Medication Administration [NCIt concept]
- Age in Days at End of Radiation Therapy [NCIt concept]
- Age in Days at End of Total Dose Calculation [NCIt concept]
- Age in Days at End of Treatment Course [NCIt concept]
- Age in Days at Enrollment [NCIt concept]
- Age in Days at Function Test [NCIt concept]
- Age in Days at Last Known Survival Status [NCIt concept]
- Age in Days at Measurable Residual Disease Assessment [NCIt concept]
- Age in Days at Molecular Analysis [NCIt concept]
- Age in Days at Onset Adverse Event [NCIt concept]
- Age in Days at Radiation Therapy Course Start [NCIt concept]
- Age in Days at Response Assessment [NCIt concept]
- Age in Days at Secondary Malignancy Neoplasm [NCIt concept]
- Age in Days at Start of Cellular Immunotherapy [NCIt concept]
- Age in Days at Start of Concomitant Medication Administration [NCIt concept]
- Age in Days at Start of Total Dose Calculation [NCIt concept]
- Age in Days at Start of Transfusion Procedure [NCIt concept]
- Age in Days at Start of Treatment Course [NCIt concept]
- Age in Days at Stem Cell Transplant [NCIt concept]
- Age in Days at Time of Laboratory Test [NCIt concept]
- Age in Days at Vitals [NCIt concept]
- Allele Ratio Measurement [NCIt concept]
- Antineoplastic Agent [NCIt concept]
- BM Analysis Modality at Response [NCIt concept]
- BM PCT Blasts At Response [NCIt concept]
- CNS Involvement Status at Leukemia Diagnosis [NCIt concept]
- Cause of Death [NCIt concept]
- Cause of Death Detail [NCIt concept]
- Cause of Death Ranking [NCIt concept]
- Chromosome [NCIt concept]
- Concomitant Agent [NCIt concept]
- Cumulative Dose [NCIt concept]
- Data Contributor ID [NCIt concept]
- Disease Involvement Detection Method [NCIt concept]
- Disease Involvement Site [NCIt concept]
- Disease Phase [NCIt concept]
- Disease Phase Number [NCIt concept]
- Disease Response [NCIt concept]
- Ethnic Group [NCIt concept]
- Extramedullary Myeloid Sarcoma Site [NCIt concept]
- First Variant Gene Symbol [NCIt concept]
- Flow Cytometry Type [NCIt concept]
- French-American-British Classification [NCIt concept]
- Function Category [NCIt concept]
- Function Result [NCIt concept]
- Function Result Measurement [NCIt concept]
- Function Result Numeric [NCIt concept]
- Function Result Unit [NCIt concept]
- Fusion Gene Downstream Gene Symbol [NCIt concept]
- GVHD Acuity [NCIt concept]
- GVHD Organ [NCIt concept]
- Gene Product Sequence Variation [NCIt concept]
- Gene Variant [NCIt concept]
- HLA Match Finding [NCIt concept]
- HLA-A Match Finding [NCIt concept]
- HLA-B Match Finding [NCIt concept]
- HLA-C Match Finding [NCIt concept]
- HLA-DQ Match Finding [NCIt concept]
- HLA-DRB1 Match Finding [NCIt concept]
- Honest Broker Subject ID [NCIt concept]
- Intensive Care Unit Admission Status [NCIt concept]
- Intervention/Medication Detail [NCIt concept]
- Karyotype ISCN [NCIt concept]
- Lab Result Unit [NCIt concept]
- Laboratory Specimen Type [NCIt concept]
- Laboratory Test Category [NCIt concept]
- Laboratory Test Method [NCIt concept]
- Laboratory Test Name [NCIt concept]
- Laboratory Test Result [NCIt concept]
- Last Known Survival Status [NCIt concept]
- Measurable Residual Disease Method [NCIt concept]
- Measurable Residual Disease Molecular Marker [NCIt concept]
- Measurable Residual Disease Response [NCIt concept]
- Measurable Residual Disease Sample Source [NCIt concept]
- Measurable Residual Disease Sensitivity [NCIt concept]
- Measurable Residual Disease Unit [NCIt concept]
- Measurable Residual Disease Value [NCIt concept]
- Medication Administration Status [NCIt concept]
- Medication Course Number [NCIt concept]
- Medication Intended Route Effect [NCIt concept]
- Mixed Phenotype Acute Leukemia [NCIt concept]
- Molecular Abnormality [NCIt concept]
- Molecular Abnormality Result Indicator [NCIt concept]
- Molecular Sequence Variation [NCIt concept]
- Myeloid Leukemia Associated with Down Syndrome [NCIt concept]
- Myeloid Sarcoma [NCIt concept]
- Number of Cells in Metaphase during Karyotyping [NCIt concept]
- Number of Doses [NCIt concept]
- Number of Evaluated HLAs [NCIt concept]
- Number of Independent Aberrations in Karyotype [NCIt concept]
- Number of Matched HLAs [NCIt concept]
- Numeric Test Result [NCIt concept]
- Numeric Vitals Signs Result [NCIt concept]
- Off Protocol Therapy or Study Code [NCIt concept]
- Off Protocol Therapy or Study Reason Code [NCIt concept]
- PCDC Subject Identifier [NCIt concept]
- Pathogen Confirmation Indicator [NCIt concept]
- Personal Medical History [NCIt concept]
- Platelet Count At Response [NCIt concept]
- Platelet Threshold At Response [NCIt concept]
- Protocol Treatment Arm [NCIt concept]
- Protocol Treatment Course [NCIt concept]
- Race [NCIt concept]
- Radiation Dose Unit [NCIt concept]
- Response Assessment Category [NCIt concept]
- SMN ICD-O Morphology Code [NCIt concept]
- SMN ICD-O Topography Code [NCIt concept]
- Secondary Acute Myeloid Leukemia [NCIt concept]
- Sex [NCIt concept]
- Site of Radiation Therapy [NCIt concept]
- Specify Molecular Abnormality Analysis Method [NCIt concept]
- Stem Cell Transplant Donor Relationship [NCIt concept]
- Stem Cell Transplant Source [NCIt concept]
- Study Identifier [NCIt concept]
- Subject Enrollment Status [NCIt concept]
- Total Dose Intended [NCIt concept]
- Total Dose Units [NCIt concept]
- Total Radiation Dose [NCIt concept]
- Total-Body Irradiation [NCIt concept]
- Transfusion Product [NCIt concept]
- Transfusion Type [NCIt concept]
- Transient Abnormal Myelopoiesis Associated with Down Syndrome [NCIt concept]
- Traumatic Tap [NCIt concept]
- Treatment-related Mortality Type [NCIt concept]
- Type of Cellular Immunotherapy [NCIt concept]
- Type of Stem Cell Transplant [NCIt concept]
- Type of Stem Cell Transplant Conditioning Prior to Transplant [NCIt concept]
- Units for Vital Signs Results [NCIt concept]
- Vital Signs Measurement [NCIt concept]
- Vital Signs Result [NCIt concept]
- WHO AML Classification of Tumors [NCIt concept]
- Year at Disease Phase [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients